|
perphenazine
|
CHEBI_8028 |
[A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.] |
|
diencephalon
|
UBERON_0001894 |
[The more posterior and ventral of two forebrain neuromeres, the other being the telencephalon; major derivatives are the eye cups, the brain pretectal region, the thalamus, hypothalamus, and epithalamus (including the habenula and epiphysis). Kimmel et al, 1995.[TAO], The division of the forebrain that develops from the foremost primary cerebral vesicle., Unpaired part of the forebrain comprised of three major parts; the epithalamus, thalamus, and hypothalamus.[AAO]] |
|
perindopril
|
CHEBI_8024 |
[An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline] |
|
CASP7
|
OGG_3000000840 |
|
|
CASP8
|
OGG_3000000841 |
|
|
CASP9
|
OGG_3000000842 |
|
|
suprofen
|
CHEBI_9362 |
[An aromatic ketone that is thiophene substituted at C-2 by a 4-(1-carboxyethyl)benzoyl group.] |
|
Phase IIb Trial
|
NCIT_C49688 |
[A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind.] |
|
Caenorhabditis elegans
|
NCBITaxon_6239 |
|
|
Phase IIa Trial
|
NCIT_C49686 |
[A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question.] |
|
hepatitis
|
MONDO_0002251 |
[An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.] |
|
3-nitrotyrosine
|
CHEBI_86269 |
[A nitrotyrosine comprising tyrosine having a nitro group at the 3-position on the phenyl ring.] |
|
etodolac
|
CHEBI_4909 |
[A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.] |
|
adverse drug effect
|
OAE_0001011 |
[an adverse effect that occurs after a drug administration: an appreciably harmful or unpleasant reaction resulting from an intervention related to the use of a medicinal product] |
|
Personality changes
|
HP_0000751 |
[An abnormal shift in patterns of thinking, acting, or feeling.] |
|
monocyclic compound
|
CHEBI_33661 |
|
|
CAV1
|
OGG_3000000857 |
|
|
inferior temporal gyrus
|
UBERON_0002751 |
[Component of the temporal lobe, lateral aspect. The rostral boundary is the rostral extent of the inferior temporal sulcus whereas the caudal boundary is designated as the temporo-occipital incisure on the cortical surface. The occipitotemporal sulcus is the medial boundary and the inferior temporal sulcus is the lateral boundary (Christine Fennema-Notestine).] |
|
TFAM
|
OGG_3000007019 |
|
|
TF
|
OGG_3000007018 |
|
